These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 600435)

  • 1. [Hormone therapy in renal adenocarcinoma].
    Giuliani L; Pescatore D; Giberti C
    Minerva Chir; 1977 Dec 15-31; 32(23-24):1463-5. PubMed ID: 600435
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regressions of pulmonary metastases of clear cell carcinoma after nephrectomy and progestogen therapy].
    Frea B; Tizzani A; Tasso M
    Minerva Urol; 1981; 33(2):97-101. PubMed ID: 7322102
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of embolization and nephrectomy in the treatment of metastatic renal carcinoma.
    Swanson DA; Wallace S; Johnson DE
    Urol Clin North Am; 1980 Oct; 7(3):719-30. PubMed ID: 7456183
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal therapy of renal cell carcinoma (RCC).
    Bracci U; DiSilverio F; Concolino G
    Prog Clin Biol Res; 1982; 100():623-40. PubMed ID: 7145993
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormonal therapy in carcinoma of the kidney.
    Di Silveiro F; La Pera G; De Matties A; De Vita R
    Arch Esp Urol; 1991 Apr; 44(3):319-23. PubMed ID: 1651072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of progestogens as an adjuvant to surgery in the treatment of stage I adenocarcinoma of the uterine corpus.
    Moazzami B; Van der Walt JD; Boyd NR
    Br J Obstet Gynaecol; 1983 Feb; 90(2):178-81. PubMed ID: 6218817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer.
    Fuks JZ; Aisner J; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Sep; 66(9):1773-4. PubMed ID: 7116354
    [No Abstract]   [Full Text] [Related]  

  • 8. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
    Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
    Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
    Tomic R; Ljungberg B; Damber JE
    Scand J Urol Nephrol Suppl; 1988; 110():185-7. PubMed ID: 2973122
    [No Abstract]   [Full Text] [Related]  

  • 10. Yoshi 864 plus medroxyprogesterone acetate in adenocarcinoma of the kidney: A Southwest Oncology Group Study.
    Altman SJ; Stephens RL; Bonnet JD
    Cancer Treat Rep; 1982 Sep; 66(9):1781-2. PubMed ID: 6288240
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal therapy in advanced renal cell carcinoma.
    Wagle DG; Murphy GP
    Cancer; 1971 Aug; 28(2):318-21. PubMed ID: 5566354
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of tamoxifen in patients with advanced renal cell carcinoma.
    Glick JH; Wein A; Torri S; Alavi J; Harris D; Brodovsky H
    Cancer Treat Rep; 1980; 64(2-3):343-4. PubMed ID: 7407768
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen in unresectable hypernephroma. A phase II trial and review of the literature.
    Weiselberg L; Budman D; Vinciguerra V; Schulman P; Degnan TJ
    Cancer Clin Trials; 1981; 4(2):195-8. PubMed ID: 7249256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of the progestogen gestonorone caproate on testosterone turnover in renal cell carcinoma. An in vitro study.
    Marberger M; Altwein JE; Orestano F
    Invest Urol; 1976 Jan; 13(4):302-6. PubMed ID: 1245393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma in a solitary kidney treated by partial nephrectomy--case report and review of Japanese literature.
    Iizumi T; Takeshima H; Umeyama T; Ishikawa S; Nemoto S; Nemoto R; Yazaki T; Kanoh S; Koiso K
    Jpn J Clin Oncol; 1983 Dec; 13(4):727-31. PubMed ID: 6645088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis of renal adenocarcinoma in a surgical series].
    Avellana JA; Silva J; Hidalgo L; Ortas J; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(4):163-6. PubMed ID: 696452
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor of the excretory duct on a solitary kidney after nephrectomy of the other kidney for Grawitz's tumor].
    Raymond G; Fournier P; Hamou JC
    J Urol Nephrol (Paris); 1975; 81(7-8):619-21. PubMed ID: 1206795
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coadjuvant treatment of renal adenocarcinoma].
    Armero AH; Avellana JA; Silva JM; Marcos J; Guinea A; Martínez-Piñeiro JA
    Actas Urol Esp; 1978; 2(4):167-70. PubMed ID: 696453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.